Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
9.24
+0.42 (4.76%)
At close: Aug 18, 2026, 4:00 PM EDT
9.33
+0.09 (0.97%)
After-hours: Aug 18, 2026, 7:59 PM EDT
Puma Biotechnology Market Cap
Puma Biotechnology has a market cap or net worth of $476.97 million as of August 18, 2026. Its market cap has increased by 65.27% in one year.
Market Cap
476.97M
Enterprise Value
387.88M
1-Year Change
65.27%
Ranking
Category
Stock Price
$9.24
ChartMarket Cap Chart
Since April 24, 2012, Puma Biotechnology's market cap has increased from $280.60M to $476.97M, an increase of 69.98%. That is a compound annual growth rate of 3.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 476.97M | 59.10% |
| Dec 31, 2025 | 299.80M | 100.27% |
| Dec 31, 2024 | 149.70M | -27.33% |
| Dec 29, 2023 | 206.00M | 6.68% |
| Dec 30, 2022 | 193.10M | 55.35% |
| Dec 31, 2021 | 124.30M | -69.53% |
| Dec 31, 2020 | 408.00M | 19.68% |
| Dec 31, 2019 | 340.90M | -56.07% |
| Dec 31, 2018 | 776.00M | -79.08% |
| Dec 29, 2017 | 3.71B | 228.21% |
| Dec 30, 2016 | 1.13B | -55.55% |
| Dec 31, 2015 | 2.54B | -55.43% |
| Dec 31, 2014 | 5.71B | 92.11% |
| Dec 31, 2013 | 2.97B | 452.60% |
| Dec 31, 2012 | 537.50M | 91.55% |
| Apr 24, 2012 | 280.60M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 480.55M |
| Cabaletta Bio | 466.25M |
| Ocugen | 457.80M |
| Ginkgo Bioworks Holdings | 457.24M |
| Larimar Therapeutics | 455.11M |
| Prothena Corporation | 454.85M |
| Q32 Bio | 451.01M |
| Eupraxia Pharmaceuticals | 442.16M |